ConforMIS Inc (NASDAQ:CFMS) insider Patricia A. Davis sold 5,794 shares of the stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $2.72, for a total value of $15,759.68. Following the completion of the sale, the insider now owns 337,310 shares of the company’s stock, valued at approximately $917,483.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
NASDAQ CFMS opened at $3.58 on Friday. ConforMIS Inc has a 1-year low of $0.36 and a 1-year high of $3.84. The company has a debt-to-equity ratio of 0.64, a quick ratio of 2.33 and a current ratio of 3.00. The firm has a market capitalization of $233.45 million, a PE ratio of -4.84 and a beta of 3.05.
ConforMIS (NASDAQ:CFMS) last posted its quarterly earnings results on Wednesday, May 1st. The medical instruments supplier reported ($0.12) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.12). ConforMIS had a negative net margin of 42.90% and a negative return on equity of 97.85%. The business had revenue of $20.64 million for the quarter, compared to the consensus estimate of $20.11 million. On average, sell-side analysts predict that ConforMIS Inc will post -0.43 EPS for the current year.
A number of institutional investors have recently bought and sold shares of CFMS. Gabelli Funds LLC increased its position in ConforMIS by 76.2% during the fourth quarter. Gabelli Funds LLC now owns 104,056 shares of the medical instruments supplier’s stock worth $37,000 after buying an additional 45,000 shares during the last quarter. Acadian Asset Management LLC increased its position in ConforMIS by 26.0% during the fourth quarter. Acadian Asset Management LLC now owns 127,166 shares of the medical instruments supplier’s stock worth $45,000 after buying an additional 26,202 shares during the last quarter. MML Investors Services LLC acquired a new position in ConforMIS during the first quarter worth $58,000. PNC Financial Services Group Inc. increased its position in ConforMIS by 100.0% during the first quarter. PNC Financial Services Group Inc. now owns 20,000 shares of the medical instruments supplier’s stock worth $58,000 after buying an additional 10,000 shares during the last quarter. Finally, Morgan Stanley increased its position in ConforMIS by 197.3% during the first quarter. Morgan Stanley now owns 20,079 shares of the medical instruments supplier’s stock worth $58,000 after buying an additional 13,325 shares during the last quarter. 34.08% of the stock is currently owned by hedge funds and other institutional investors.
Conformis, Inc, a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a customized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee.
See Also: Preferred Stock
Receive News & Ratings for ConforMIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConforMIS and related companies with MarketBeat.com's FREE daily email newsletter.